Trademark: 79256134
Word
DBLG1
Status
Registered
Status Code
700
Status Date
Tuesday, June 2, 2020
Serial Number
79256134
Registration Number
6066262
Registration Date
Tuesday, June 2, 2020
Mark Type
4000
Filing Date
Tuesday, December 4, 2018
Published for Opposition
Tuesday, March 17, 2020

Trademark Owner History
DIABELOOP - Original Registrant

Classifications
9 Downloadable databases enabling computer storage and reading of data in the field of medical statistics; data processing equipment, namely, calculators; recorded computer software for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; downloadable computer programs for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; data downloadable on a computer or on a mobile telephone, namely, downloadable files containing medical information; computer terminals; mobile data terminals (MDT); Internet and intranet servers; computer and network servers; computer database servers; computer peripheral devices; intercommunication apparatus, namely, telephones and dedicated mobile handsets incorporating intercommunication systems; computer interface boards; electronic card readers being data processing equipment; downloadable electronic publications in the nature of books, electronic books, magazines, and newsletters, in the field of medicine and science; wearable activity sensors in the nature of wearable activity tracker; diagnostic apparatus for detection of hypoglycemia and hyperglycemia not for medical use; sensors, namely, pressure and temperature sensors; downloadable computer application software for treatment of diabetes; downloadable software applications for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; downloadable software applications for mobile devices for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; information display terminals in the nature of liquid crystal displays (LCDs); electronic devices for digital display, namely, electronic display interfaces
44 Medical services; medical analysis services to diagnose and treat people; medical information; providing medical information provided via the Internet; providing information via the Internet in the field of diabetes; providing medical information; diabetes screening service; medical services in the field of diabetes; medical screening; medical testing for diagnostic or treatment purposes, medical care, physical examinations services, and medical treatment; advisory services concerning medical services; medical assistance; medical evaluation services, namely, medical testing for diagnostic or treatment purposes; medical consultation; medical technical assistance services relating to health, namely, medical assistance services provided via the internet for individuals with health problems through the use of wearable medical devices with automated alert and monitoring capacity; health services, namely, administration of insulin; hospital services; surgical treatments for diabetes or its effects; telemedicine services; advisory services relating to health; pharmaceutical advice; medical equipment rental; telemedicine services in the nature of telediagnosis services rendered via the Internet; telemedicine services in the nature of telediagnosis services including the remote transmission of medical data
10 Diagnostic test apparatus for medical purposes, namely, for the prevention and treatment of diabetes; diagnostic apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, thermometers; blood testing apparatus; medical apparatus and instruments, namely, infusion and injection devices for administering drugs and other medicaments; Surgical instruments and apparatus; pumps for medical use, namely, subcutaneous diffusion pumps for insulin and other hormones used in diabetes treatment; apparatus for measuring blood sugar for medical purposes; medical diagnostic apparatus for testing blood glucose levels; insulin syringes for medical purposes, sold empty; sensors used for medical diagnosis, namely, glucose sensors; sensors for medical use for monitoring patients' vital signs; medical test kits for home monitoring of diabetes
42 Evaluations and assessments in the fields of science and technology provided by engineers, namely, testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, and physical activity levels, and providing related reports and alerts; scientific research; technical research in the field of medicine; design and development of computers and software; research and development of new products for others; technical project study in the nature of scientific research in the field of medicine; development design, installation, maintenance, updating and rental of software; computer programming; computer system analysis; computer system design; consultancy relating to computers, namely, computer software consultancy; digitization of documents; software as a service (SaaS) services featuring software for use in database management in the medical field; information technology (IT) consultancy; hosting of servers; development and testing of computer programs, namely, computing methods and algorithms therein; development and testing of computer software; data hosting in the nature of server hosting; computer data security services, namely, restricting unauthorized network access to hard drives and computer servers; design and development of data processing programs; medical research services; providing online, non-downloadable computer programs for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management

Trademark Events
Apr 3, 2023
Change Of Name/Address Rec'd From Ib
Oct 17, 2020
Final Decision Transaction Processed By Ib
Sep 25, 2020
Final Disposition Notice Sent To Ib
Sep 25, 2020
Final Disposition Processed
Sep 2, 2020
Final Disposition Notice Created, To Be Sent To Ib
Jun 2, 2020
Registered-Principal Register
Mar 17, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 17, 2020
Published For Opposition
Mar 13, 2020
Notification Processed By Ib
Feb 26, 2020
Notification Of Possible Opposition Sent To Ib
Feb 26, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 26, 2020
Notification Of Notice Of Publication E-Mailed
Feb 13, 2020
Approved For Pub - Principal Register
Feb 12, 2020
Examiner's Amendment Entered
Feb 12, 2020
Notification Of Examiners Amendment E-Mailed
Feb 12, 2020
Examiners Amendment E-Mailed
Feb 12, 2020
Examiners Amendment -Written
Feb 6, 2020
Assigned To Examiner
Nov 15, 2019
Teas/Email Correspondence Entered
Nov 15, 2019
Correspondence Received In Law Office
Nov 15, 2019
Assigned To Lie
Nov 8, 2019
Teas Response To Office Action Received
Jun 1, 2019
Refusal Processed By Ib
May 11, 2019
Non-Final Action Mailed - Refusal Sent To Ib
May 10, 2019
Refusal Processed By Mpu
Apr 20, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Apr 19, 2019
Non-Final Action Written
Apr 16, 2019
Application Filing Receipt Mailed
Apr 12, 2019
Assigned To Examiner
Apr 12, 2019
New Application Office Supplied Data Entered
Apr 11, 2019
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24